Mitigating Risk: Safeguarding Commercialization Timelines with Shipping Validation

Advancing therapeutics from early development into commercial readiness requires an understanding of how products behave not only in controlled laboratory environments, but throughout the logistical pathways they navigate. While formulation, manufacturing, and stability evaluations are established components of development programs, the conditions encountered during transportation can introduce additional mechanical and…

The Price is Right……Or Is It? Budgeting for Drug Development Without Breaking the Bank or Your Molecule

When it comes to injectable drug development, “price” is never just a number. It’s a strategic decision. For early-stage biopharma companies, budgets are more than tight - they’re make-or-break. Every dollar spent can either accelerate a program to IND or drain resources from the next critical milestone. But in a world…

Get Smart! Experts Consider These Two Factors when Choosing the Right CDMO for Developing Injectable Medicines

When it comes to launching a new injectable medicine, there's no cheat sheet or crystal ball. But there is a smart way forward. If you're a biopharma innovator staring down a maze of timelines, compliance hurdles, and tight budgets, it’s time to get smart about your Contract Development and Manufacturing Organization (CDMO) partner. The…

Posts pagination